<DOC>
	<DOCNO>NCT01435278</DOCNO>
	<brief_summary>To date , clinical evidence efficacy safety Glucosanol maintain weight loss beyond study duration 12 week . The rationale open-label study assess efficacy prevent regain loss body weight safety Glucosanol subject overweight obese long period initial weight loss .</brief_summary>
	<brief_title>Efficacy Safety Glucosanol Maintaining Body Weight</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<criteria>Previously enrol , comply , complete INQ/K/003411 ( Glucosanol weight loss ) study , weight loss least 3 % baseline body weight Age 18 60 year time inclusion INQ/K/003411 study BMI 2535 time inclusion INQ/K/003411 study Expressed desire weight maintenance Accustomed 3 main meal per day Commitment avoid use weight loss product study Femalesʼ agreement use appropriate birth control method active study period Subject declare write his/her consent participate , understand requirement study willing comply Known sensitivity ingredient device ( Phaseolus vulgaris member Fabaceae family ) History diabetes mellitus • Fasting blood glucose 7 mmol/L History clinical sign endocrine disorder may influence body weight ( e.g . Cushingʼs disease , thyroid gland disorder ) Clinically relevant excursion safety parameter Current use antidepressant Presence acute chronic gastrointestinal disease ( e.g . IBD , coeliac disease , pancreatitis ) Uncontrolled hypertension ( 160/110 mm Hg ) Stenosis GI tract Bariatric surgery Abdominal surgery within last 6 month prior enrollment History eat disorder like bulimia , anorexia nervosa within past 12 month Other serious organ systemic disease cancer Any medication could influence GI function antibiotic , laxative , opioids , glucocorticoid , anticholinergic , antidiarrheal Pregnancy nurse Any medication use product treatment obesity ( e.g . Orlistat , fatbinder , carb/starch blocker , fatburner , satiety product etc . ) More 3 hour strenuous sport activity per week History abuse drug , alcohol medication Smoking cessation within 6 month prior enrolment Inability comply due language difficulty Presence factor ( ) , investigatorʼs judgement , preclude subject participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Weight maintenance</keyword>
	<keyword>BMI</keyword>
	<keyword>Body weight</keyword>
	<keyword>Overweight</keyword>
	<keyword>Obesity</keyword>
	<keyword>Satiety</keyword>
</DOC>